ONESOURCE SPECIALTY PHARMA LTD
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clini… Read more
ONESOURCE SPECIALTY PHARMA LTD (ONESOURCE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.007x
Based on the latest financial reports, ONESOURCE SPECIALTY PHARMA LTD (ONESOURCE) has a cash flow conversion efficiency ratio of -0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹-399.21 Million) by net assets (₹59.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ONESOURCE SPECIALTY PHARMA LTD - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how ONESOURCE SPECIALTY PHARMA LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ONESOURCE SPECIALTY PHARMA LTD Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ONESOURCE SPECIALTY PHARMA LTD ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bozhon Precision Industry Technology Co. Ltd. A
SHG:688097
|
0.085x |
|
RAPT Therapeutics Inc
NASDAQ:RAPT
|
-0.082x |
|
Herbalife Nutrition Ltd
NYSE:HLF
|
-0.229x |
|
DBG Technology Co Ltd Class A
SHE:300735
|
0.068x |
|
Beijing Watertek Information Technology Co Ltd
SHE:300324
|
0.004x |
|
Wangfujing
SHG:600859
|
0.035x |
|
Youngone
KO:111770
|
0.092x |
|
Keller Group plc
PINK:KLRGF
|
0.199x |
Annual Cash Flow Conversion Efficiency for ONESOURCE SPECIALTY PHARMA LTD (2023–2025)
The table below shows the annual cash flow conversion efficiency of ONESOURCE SPECIALTY PHARMA LTD from 2023 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹75.29 Billion | ₹-24.69 Million | 0.000x | +99.88% |
| 2024-03-31 | ₹3.96 Billion | ₹-1.07 Billion | -0.271x | -30.74% |
| 2023-03-31 | ₹7.85 Billion | ₹-1.63 Billion | -0.207x | -- |